Topical Drug Delivery to the Posterior Segment of the Eye
Topical drug delivery to the posterior segment of the eye is a very complex challenge. However, topical delivery is highly desired, to achieve an easy-to-use treatment option for retinal diseases. In this review, we focus on the drug characteristics that are relevant to succeed in this challenge. An...
Saved in:
Main Authors: | Marina Löscher (Author), Chiara Seiz (Author), José Hurst (Author), Sven Schnichels (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles
by: Kohei Tahara, et al.
Published: (2017) -
Updates on drug bioavailability and delivery to posterior segment of eye
by: Himanshu Gupta
Published: (2013) -
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
by: Rubén Varela-Fernández, et al.
Published: (2020) -
Lipid-DNA Nanoparticles as Drug-Delivery Vehicles for the Treatment of Retinal Diseases
by: Sven Schnichels, et al.
Published: (2023) -
Penetration Enhancers for Topical Drug Delivery to the Ocular Posterior Segment-A Systematic Review
by: Abhinav Thareja, et al.
Published: (2021)